Both in Pharmaceuticals
IDEAYA Biosciences vs Dyne Therapeutics
Over the past year IDYA returned +1.1% and DYN returned −29.1%; their daily moves had a correlation of 0.42.
IDYA +1.1% DYN −29.1%Growth of $1, one year, split-adjusted
| Metric | IDYA | DYN |
|---|---|---|
| Price | $31.96 | $16.69 |
| Market cap | $3.08B | $3.12B |
| Today | −2.83% | −2.05% |
| 1 month | −15.5% | +5.5% |
| 6 months | +13.4% | −4.0% |
| Year to date | −7.5% | −14.7% |
| 1 year | −0.7% | −29.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | 100.0% | — |
| Net margin | −1269.6% | — |
| P/E (TTM) | — | — |
| Price / sales | 13.2× | — |
| Net cash | $829.0M | $685.0M |
| Dividend yield | — | — |
| Volatility (60d) | 37.3% | 58.2% |
| Short % of float | 10.4% | 14.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).